Phospholipase c-inhibiting peptides
PCT No. PCT/US95/01861 Sec. 371 Date Nov. 8, 1996 Sec. 102(e) Date Nov. 8, 1996 PCT Filed Feb. 14, 1995 PCT Pub. No. WO96/28466 PCT Pub. Date Sep. 19, 1996The present invention relates to phospholipase C-inhibiting peptides which are represented by formula (I): (I) wherein n represents 0 or 1; each...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | PCT No. PCT/US95/01861 Sec. 371 Date Nov. 8, 1996 Sec. 102(e) Date Nov. 8, 1996 PCT Filed Feb. 14, 1995 PCT Pub. No. WO96/28466 PCT Pub. Date Sep. 19, 1996The present invention relates to phospholipase C-inhibiting peptides which are represented by formula (I): (I) wherein n represents 0 or 1; each J1 and J2 is a hydrogen atom, or J1 and J2 are combined together to form a single bond; W represents a hydrogen atom, a substituted or unsubstituted alkanoyl group, a substituted or unsubstituted aroyl group or coumaryl group; X represents a single bond, -Leu-, or -Ser-Leu-Val-Glu-Leu-Val-Ser-Tyr-Tyr-Glu-Lys-His-Ala-Leu- (wherein at least one amino acid residue may be deleted, inserted or substituted); Y represents a single bond or -Pro-Val-; R1 represents a hydrogen atom, a substituted or unsubstituted alkyl group or a substituted or unsubstituted aryl group; and R2 represents a substituted or unsubstituted alkyl group or a substituted or unsubstituted aryl group. |
---|